MedPath

Neurofeedback-enhanced Mindfulness Meditation in Traumatic Brain Injury

Not Applicable
Completed
Conditions
Traumatic Brain Injury
Interventions
Device: EEG neurofeedback-assisted meditation
Device: Non-EEG feedback-assisted meditation
Registration Number
NCT02615535
Lead Sponsor
Spaulding Rehabilitation Hospital
Brief Summary

Spaulding Rehabilitation Hospital is conducting a research study evaluating the effectiveness of the brain-training product, MUSE, an EEG-guided neurofeedback device designed to assist in cultivating a relaxed, attentive state of mind during meditation. The investigators study aims to evaluate whether such a tool could be useful in treating persistent traumatic brain injury symptoms such as inattention, impulsivity, irritability, or dysregulated mood.

Detailed Description

Twenty subjects in total will participate in this study. Subjects will be randomized to focused-attention meditation training with or without the neurofeedback device, MUSE. Subjects will be asked to practice \~10 min of daily meditation for 6-8 weeks. Neuropsychological testing will be performed at the beginning of the study and after six weeks of training. At this time point, those randomized to the non-MUSE group will be given a device and asked to train for an additional two weeks. At the conclusion of the study, all subjects will also undergo a brief telephone or in-person exit interview regarding their experiences using the MUSE device.

Primary endpoint: change in Neurobehavioral Symptom Inventory

Secondary endpoints: change in the following: Wechsler Adult Intelligence Scale-IV Digit Span and Symbol-Digit Coding, Trail-Making Test, Beck Anxiety Inventory, Beck Depression Inventory, Cognitive and Affective Mindfulness Scale-Revised, percentage of EEG activity associated with alpha, beta, or theta activity.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
25
Inclusion Criteria
  1. history of mild-moderate traumatic brain injury
  2. impaired attention or concentration
  3. >1 year since traumatic brain injury
  4. ability to participate in neurofeedback and mindfulness meditation
  5. daily access to a smart phone
  6. on stable dosage of neuropsychological medications with no significant changes planned for the duration of the study
  7. no prior history of a meditation practice
Exclusion Criteria
  1. severe mental illness or psychological symptoms (severe depression, suicidality, disabling anxiety, PTSD, psychosis, dissociation)
  2. significant pre-morbid learning disability
  3. current or recent (in past year) history of significant drug or alcohol abuse
  4. medical illness severe enough to result in an attentional disorder
  5. neurodegenerative disease
  6. non-fluency in English.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
EEG neurofeedback-assisted meditationEEG neurofeedback-assisted meditationEEG neurofeedback assisted meditation using the MUSE device and auditory feedback.
Non-EEG feedback-assisted meditationNon-EEG feedback-assisted meditationNon-EEG neurofeedback assisted meditation. Subjects will have auditory instruction from the MUSE device without the EEG neurofeedback.
Primary Outcome Measures
NameTimeMethod
Change in Neurobehavioral Symptom Inventorybaseline and six weeks

Measures common symptoms after head injury. This scales ranges from 0-4 on 22 items, for a minimum score of 0 and a maximum score of 88. Higher scores mean a greater severity of symptoms.

Secondary Outcome Measures
NameTimeMethod
Change in Trail Making Testbaseline and six weeks

Subjects are asked to sequence numbers and letters represented on a page as quickly as then can. Results are measured in seconds, ranging from 0 (hypothetically) to an infinite number (hypothetically). Results are scaled from 1 to 19. Lower scores mean a better outcome.

Change in Beck Depression Inventory-IIbaseline and six weeks

Subjects respond to questions on a Likert scale from 0-3 regarding depressive symptoms. There are 21 items. Scores range from 0-63. Lower scores mean a better outcome.

Change in Wechsler Adult Intelligence Scale-IV Digit Symbol Codingbaseline and six weeks

A subject is provided with a key matching nine numbers to nine unique symbols. Numbers are then provided in random order and subjects have 120 seconds to match as many numbers with symbols as possible. All correct responses are scored. Scores range from 0 to 135. Scores are later scaled from 1 to 19. Higher scores mean a better outcome.

Change in Beck Anxiety Inventorybaseline and six weeks

Subjects rate on a 0-3 likert scales responses to questions about anxiety. Scores range from 0-63. Lower scores mean a better outcome.

Change in Cognitive and Affective Mindfulness Scale-Revisedbaseline and six weeks

Subjects answer questions regarding mindfulness on a Likert Scale from 1-4. There are twelve questions total. Scores range from 4-48. Higher scores mean a better outcome.

Change in Wechsler Adult Intelligence Scale-IV Digit Spanbaseline and six weeks

Tests participants digit span, repeating forward sequences of digits from 2 to 8. Scale ranges from 0 to 16. Higher scores mean a better outcome.

Change in Percentage of EEG Activity Associated With Alpha, Beta, and Theta Rhythms as Measured by Surface Electrodes on the MUSE Devicebaseline and at six weeks

Change in "percent Calm" as determined by Muse device. Equations behind this algorithm to determine "Calm" are proprietary and were not shared by the device manufacturer. Ranges from 0% to 100%. Higher scores mean a better outcome.

Trial Locations

Locations (1)

Spaulding Rehabilitation Hospital Boston

🇺🇸

Charlestown, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath